21.20 or 72.10: the difference between NACE codes
Related: one code is mentioned in the other's “Excludes”
21.20 Manufacture of pharmaceutical preparations
C Manufacturing › 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations › 21.2 Manufacture of pharmaceutical preparations
Includes
- manufacture of medicaments:
- antisera and other blood fractions
- vaccines
- diverse medicaments, including homeopathic preparations
- manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments
- manufacture of medical diagnostic preparations, including pregnancy tests
- manufacture of radioactive in-vivo diagnostic substances
- manufacture of cell and gene advance therapy medical products
Also includes
- manufacture of medical impregnated wadding, gauze, bandages, dressings, etc.
- preparation of botanical products (grinding, grading, milling) for pharmaceutical use
- manufacture of viral vector-based medicines or vaccines
- manufacture of pharmaceutical preparations for veterinary medicines
Excludes
- manufacture of herb infusions (mint, vervain, chamomile, etc.), see 10.83
- manufacture of probiotics, see 21.10
- manufacture of dental fillings and dental cement, see 32.50
- manufacture of bone reconstruction cements, see 32.50
- manufacture of surgical drapes, see 32.50
- wholesale of pharmaceuticals, see 46.46
- retail sale of pharmaceuticals, see 47.73
- research and development for pharmaceuticals and other biotech products, see 72.10
- packaging of pharmaceuticals, see 82.92
Previously (NACE Rev. 2)
21.20 Manufacture of pharmaceutical preparations (same code)
EMTAK
21201 Ravimpreparaatide tootmine
EVRK
212000 Farmacinių preparatų gamyba
Companies with this code
72.10 Research and experimental development on natural sciences and engineering
N Professional, scientific and technical activities › 72 Scientific research and development › 72.1 Research and experimental development on natural sciences and engineering
Includes
- research and experimental development on natural sciences and engineering:
- research and development on natural sciences
- research and development on engineering and technology
- research and development on medical, health and life, and veterinary sciences
- research and development on biotechnology
- research and development on agricultural, forestry and fisheries sciences
- interdisciplinary research and development, predominantly on natural sciences and engineering
Also includes
- DNA sequencing for general research on biological processes
Excludes
- DNA sequencing for ruling out or curing a specific disease, see 86.91
Previously (NACE Rev. 2)
72.11 Research and experimental development on biotechnology (merged); 72.19 Other research and experimental development on natural sciences and engineering (merged)
EMTAK
72101 Teadus- ja arendustegevus loodus- ja tehnikateaduste vallas
EVRK
721010 Gamtos mokslų tyrimai ir taikomoji veikla; 721020 Medicinos mokslų tyrimai ir taikomoji veikla; 721030 Technologijų mokslų tyrimai ir taikomoji veikla; 721090 Kitų gamtos mokslų ir inžinerijos moksliniai tyrimai ir taikomoji veikla
Companies with this code
Official statistics (Eurostat, 2024): 21.20 Manufacture of pharmaceutical preparations
Figures for NACE Rev. 2 class 21.20, which corresponds to this position.
| Country | Companies | Persons employed | Persons employed per enterprise | Turnover, € million | Turnover per person employed, € thousand | Value added, € million | Average personnel costs per employee, € thousand |
|---|---|---|---|---|---|---|---|
| LV Latvia | 24 | 1,910 | 80.0 | not published | not published | not published | not published |
| EE Estonia | 10 | not published | not published | not published | not published | not published | not published |
| LT Lithuania | 20 | not published | not published | not published | not published | not published | not published |
Change since 2022: in Latvia — enterprises −7.7%, persons employed −11.8%; in Estonia — enterprises −16.7%; in Lithuania — enterprises +11.1%
In statistics an enterprise is an economically active unit (including the self-employed), whereas Regmio counts register entries with a declared main activity code, so the figures differ. Source: Eurostat, structural business statistics (sbs_ovw_act), updated 30.09.2026.
Official statistics (Eurostat, 2024): 72.10 Research and experimental development on natural sciences and engineering
There are no separate figures for this class; group 72.1 Research and experimental development on natural sciences and engineering is shown (NACE Rev. 2 72.1). 72.1 →
| Country | Companies | Persons employed | Persons employed per enterprise | Turnover, € million | Turnover per person employed, € thousand | Value added, € million | Average personnel costs per employee, € thousand |
|---|---|---|---|---|---|---|---|
| LV Latvia | 220 | 691 | 3.0 | 37.6 | 54.3 | 20.4 | 28.7 |
| EE Estonia | 388 | 1,572 | 4.0 | 124.7 | 79.3 | 71.8 | 50.1 |
| LT Lithuania | 1,190 | 3,291 | 3.0 | 231.1 | 70.2 | 111.2 | 35.5 |
Change since 2022: in Latvia — enterprises +14.6%, persons employed +26.8%; in Estonia — enterprises +4.9%; in Lithuania — enterprises +9.8%, persons employed +6.9%
In statistics an enterprise is an economically active unit (including the self-employed), whereas Regmio counts register entries with a declared main activity code, so the figures differ. Source: Eurostat, structural business statistics (sbs_ovw_act), updated 30.09.2026.
Sources: Eurostat, NACE Rev. 2.1 (© European Union, CC BY 4.0); Central Statistical Bureau of Latvia (Latvian titles, CC0); Valstybės duomenų agentūra (EVRK Rev. 2.1, CC BY 4.0); RIK e-äriregister (EMTAK 2025). Classification data: 2026-11-16. Download the dataset (CSV, JSON)